Study for mechanism of electroacupuncture intervention based on PD-1 pathway for immune disorder of sepsis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024650

Enrollment

Unknown

Registered

2019-07-19

Start date

2019-07-08

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Interventions

Control group:Conventional treatment

Experimental group:Conventional treatment and Electric needle treatment on Zusanli, Guan yuan and Qi hai

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to the intensive care unit (ICU) of The Second Affiliated Hospital of Guangzhou University of Chinese Medicine and diagnosed with sepsis; 2. Aged 18-85 years old; 3. Sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or mentally illness; 2. Immunodeficiency patients; Using hormones or immunosuppressants; 3. HIV-ab positive; 4. Unwilling to participate in the trial or cooperate with treatment.

Design outcomes

Primary

Measure	Time frame
T lymphocyte subsets;B cells;natural killer cell;INF-?;IL-4;28-day mortality;	—

Countries

China

Contacts

Public ContactGuang Yang

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

yg_1918@163.com+86 13580421600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026